Express Pharma

Lupin receives EIR from US FDA for Goa, July 2015 inspection


The responses from March 2016 US FDA inspection are still under review

Lupin has announced that it has received notification that the inspection carried out by the US FDA in July 2015 at its Goa facility is now closed and the agency has issued an Establishment Inspection Reports (EIR). However, the responses from the March 2016 US FDA inspection and updates thereafter are still under review by the agency.

Comments are closed.